Unadjusted HR | 95% CI | p Value | |
COR group (referent) | 1 | ||
SR vs COR group | 0.372 | 0.198 to 0.699 | 0.002 |
CR vs COR group | 0.409 | 0.225 to 0.742 | 0.003 |
Age | 1.013 | 0.991 to 1.034 | 0.253 |
Male sex | 0.914 | 0.522 to 1.601 | 0.753 |
Diabetes mellitus | 1.727 | 1.025 to 2.910 | 0.040 |
Hypertension | 1.254 | 0.768 to 2.048 | 0.366 |
LVEF before PCI | 0.977 | 0.953 to 1.002 | 0.068 |
LVEF at discharge | 0.987 | 0.958 to 1.018 | 0.412 |
Anterior STEMI | 1.083 | 0.667 to 1.735 | 0.738 |
3 vessel CAD | 1.078 | 0.649 to 1.791 | 0.771 |
TIMI flow before PCI | 0.875 | 0.714 to 1.074 | 0.202 |
Killip class | 1.862 | 1.331 to 2.605 | <0.001 |
Drug-eluting stent | 0.864 | 0.393 to 1.897 | 0.715 |
Chronic renal failure | 1.852 | 1.127 to 3.041 | 0.015 |
CIN | 3.350 | 1.342 to 8.364 | 0.010 |
CAD, coronary artery disease; CIN, contrast-induced nephropathy; COR, culprit-only revascularisation; CR, complete revascularisation; HR, hazard ratio; LVEF, left ventricular ejection fraction; MACE, major adverse cardiac event; PCI, percutaneous coronary intervention; SR, staged revascularisation; STEMI, ST-elevation myocardial infarction; TIMI, Thrombolysis In Myocardial Infarction.